US 8304422
Compositions and methods for inhibition of the JAK pathway
granted A61PA61P37/00A61P37/06
Quick answer
US patent 8304422 (Compositions and methods for inhibition of the JAK pathway) held by Rigel Pharmaceuticals, Inc. expires Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Nov 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61P, A61P37/00, A61P37/06